Bill > SB00391

This bill requires individual and group health insurance policies to provide coverage for biomarker testing. Biomarker testing is a diagnostic method that involves analyzing biological molecules (such as proteins, genes, or other molecular markers) to detect specific health conditions, assess disease risk, or guide treatment decisions. By mandating this coverage, the bill aims to ensure that patients have access to these potentially critical diagnostic tests without facing additional out-of-pocket expenses. The legislation would modify Chapter 700c of the general statutes to implement this requirement, making biomarker testing a standard covered service for health insurance plans in the jurisdiction. This could potentially help patients receive more personalized and precise medical care by enabling early detection, more accurate diagnoses, and more targeted treatment strategies.

Business and Industry

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00391&which_year=2025